Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use. - Université de Bretagne Occidentale Access content directly
Journal Articles Haematologica Year : 2006
No file

Dates and versions

hal-00689153 , version 1 (19-04-2012)

Identifiers

  • HAL Id : hal-00689153 , version 1
  • PUBMED : 16533732

Cite

Aurelien Delluc, Elisabeth Pasquier, Luc de Saint Martin, Dominique Mottier. Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.. Haematologica, 2006, 91 (3), pp.ECR05. ⟨hal-00689153⟩
24 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More